DaVita Inc. (DVA)
NYSE: DVA · IEX Real-Time Price · USD
137.95
+1.89 (1.39%)
At close: Jul 19, 2024, 4:00 PM
139.00
+1.05 (0.76%)
Pre-market: Jul 22, 2024, 7:02 AM EDT
DaVita Employees
DaVita had 70,000 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
70,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$176,257
Profits / Employee
$11,652
Market Cap
12.10B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 70,000 | 0 | - |
Dec 31, 2022 | 70,000 | 1,000 | 1.45% |
Dec 31, 2021 | 69,000 | 2,000 | 2.99% |
Dec 31, 2020 | 67,000 | 2,000 | 3.08% |
Dec 31, 2019 | 65,000 | -12,700 | -16.34% |
Dec 31, 2018 | 77,700 | 3,200 | 4.30% |
Dec 31, 2017 | 74,500 | 4,200 | 5.97% |
Dec 31, 2016 | 70,300 | 9,900 | 16.39% |
Dec 31, 2015 | 60,400 | 2,500 | 4.32% |
Dec 31, 2014 | 57,900 | 500 | 0.87% |
Dec 31, 2013 | 57,400 | 4,000 | 7.49% |
Dec 31, 2012 | 53,400 | 12,400 | 30.24% |
Dec 31, 2011 | 41,000 | 4,500 | 12.33% |
Dec 31, 2010 | 36,500 | 2,500 | 7.35% |
Dec 31, 2009 | 34,000 | 1,500 | 4.62% |
Dec 31, 2008 | 32,500 | 1,500 | 4.84% |
Dec 31, 2007 | 31,000 | 2,100 | 7.27% |
Dec 31, 2006 | 28,900 | 900 | 3.21% |
Dec 31, 2005 | 28,000 | 12,700 | 83.01% |
Dec 31, 2004 | 15,300 | 1,500 | 10.87% |
Dec 31, 2003 | 13,800 | 800 | 6.15% |
Dec 31, 2002 | 13,000 | 300 | 2.36% |
Dec 31, 2001 | 12,700 | 500 | 4.10% |
Dec 31, 2000 | 12,200 | -100 | -0.81% |
Dec 31, 1999 | 12,300 | 0 | - |
Dec 31, 1998 | 12,300 | 3,470 | 39.30% |
Dec 31, 1997 | 8,830 | 5,705 | 182.56% |
Dec 31, 1996 | 3,125 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Fresenius Medical Care AG & Co. KGaA | 119,845 |
Universal Health Services | 96,700 |
Dr. Reddy's Laboratories | 27,048 |
Charles River Laboratories International | 21,800 |
Smith & Nephew | 19,081 |
Natera | 3,293 |
Bio-Techne | 3,050 |
Legend Biotech | 1,826 |
DVA News
- 3 days ago - DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call - PRNewsWire
- 5 days ago - Renal Denervation Devices Market Expected to Reach USD 387 Million by 2032 with a Remarkable 37.2% CAGR, According to Straits Research - GlobeNewsWire
- 8 days ago - US FTC probing DaVita, Fresenius Medical, Politico reports - Reuters
- 5 weeks ago - DaVita, Nuwellis Extend Pilot Collaboration for Aquadex - Benzinga
- 2 months ago - DaVita Celebrates Corporate Citizenship Achievements with Release of 2023 Community Care Report - PRNewsWire
- 2 months ago - DaVita Appoints New Chief Information Officer - PRNewsWire
- 2 months ago - DaVita Inc. to Participate in the BofA Securities 2024 Health Care Conference - PRNewsWire
- 2 months ago - DaVita Honors 54 Nephrology Nurses with DAISY Awards - PRNewsWire